TriAgenics is a specialized medical device manufacturer focused on preventing the formation of wisdom teeth. Their core mission is to offer innovative solutions that enhance dental health and reduce the need for future surgical interventions. The company’s flagship product, the Zero3™ TBA (3rd Molar Tooth Bud Ablation), is a one-minute treatment designed to safely and effectively prevent the development of wisdom teeth by gently warming the center of the developing tooth buds.
TriAgenics has demonstrated significant efficacy and safety in multiple live animal trials, with no observed adverse outcomes other than one post-operative infection. This groundbreaking approach aims to revolutionize dental care by eliminating the common issues associated with wisdom teeth. The company's innovative technology and commitment to improving dental health have positioned it as a leader in the medical device industry.
